NASDAQ:FATE

Fate Therapeutics Stock Forecast

etoro logo Buy FATE
*Your capital is at risk
$1.96
+0.0600 (+3.16%)
At Close: Jun 17, 2026
AI Analysis AI Analysis of FATE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add FATE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Wednesday for Fate Therapeutics
(Updated on Jun 17, 2026)

Sell candidate since Jun 15, 2026 Loss -2.49%

The Fate Therapeutics stock price gained 3.16% on the last trading day (Wednesday, 17th Jun 2026), rising from $1.90 to $1.96. During the last trading day the stock fluctuated 8.24% from a day low at $1.88 to a day high of $2.04. The price has fallen in 7 of the last 10 days and is down by -11.71% for this period. Volume fell on the last day by -210 thousand shares and in total, 2 million shares were bought and sold for approximately $3.23 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.92 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 76.96% during the next 3 months and, with a 90% probability hold a price between $3.40 and $5.52 at the end of this 3-month period.

FATE Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fate Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.07. On a fall, the stock will find some support from the short-term average at $1.95. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -30.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Fate Therapeutics stock

Fate Therapeutics finds support from accumulated volume at $1.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.155 between high and low, or 8.24%. For the last week, the stock has had daily average volatility of 8.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FATE) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Fate Therapeutics to open at $1.96, and during the day (based on 14 day Average True Range), to move between $1.85 and $2.07, which gives a possible trading interval of +/-$0.210 (+/-11.33%) up or down from last closing price. If Fate Therapeutics takes out the full calculated possible swing range there will be an estimated 11.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.90 (3.06%) than the resistance at $2.22 (13.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fate Therapeutics stock A Buy?

The Fate Therapeutics stock holds several negative signals and despite the positive trend, we believe Fate Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.597 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 18, 2026 - $1.96 ( 0.0850%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

FATE Performance

Trading levels for FATE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.11 7.82%
R2 2.05 4.80%
R1 2.02 2.94%
Price 1.96
S1 1.90 -3.11%
S2 1.86 -4.97%
S3 1.80 -7.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.36 20.41%
R2 2.25 14.80%
R1 2.22 13.27%
Price 1.96
S1 1.90 -3.06%
S2 1.89 -3.57%
S3 1.80 -8.16%

FAQ

What is the symbol for Fate Therapeutics Stock and on which exchange is it traded?
The symbol for Fate Therapeutics is FATE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fate Therapeutics Stock?
The Fate Therapeutics stock holds several negative signals and despite the positive trend, we believe Fate Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Fate Therapeutics Stock?
Fate Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fate Therapeutics Stock.

What's the current price of Fate Therapeutics Stock?
As of the end of day on the Jun 17, 2026, the price of an Fate Therapeutics (FATE) share was $1.96.

What is the 52-week high and low for Fate Therapeutics Stock?
The 52-week high for Fate Therapeutics Stock is $2.88 and the 52-week low is $0.91.

What is the market capitalization of Fate Therapeutics Stock?
As of the Jun 17, 2026, the market capitalization of Fate Therapeutics is 228.456M.

When is the next earnings date for Fate Therapeutics?
The upcoming earnings date for Fate Therapeutics is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT FATE THERAPEUTICS
Fate Therapeutics
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE